Summary
- Current Price
- As of today, UNCY price is $5.43, up +1.31% on
- Current Price All-Time High
- UNCY price is currently -93.78% below its historical high of $87.30 set on
- Market Cap
- UNCY current market cap is $149M, up +124.74% over the past 365 days
- PE Ratio
- UNCY PE ratio is unknown
- Revenue
- UNCY current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for UNCY has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | Unicycive Therapeutics, Inc. |
| Ticker | NASDAQ: UNCY |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | unicycive.com |
| Employees | 22 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.43 | ||
| Price, 1D Change | +1.31% | |
| $149M | ||
| - | ||
| - | ||
| 1.02 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.67 | ||
| EPS, 1Y Change | +70.40% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:10 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.67 | ||
| EPS Estimate | N/A | -$1.42 |
| EPS Est. Change | N/A | +15.35% |
| $0.00 | ||
| Revenue Estimate | N/A | $4.23M |
| Revenue Est. Change | N/A | - |
| $5.43 | ||
| Price Target | - | $37.00 |
| Price Tgt. Change | - | +581.40% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.51 | -$5.65 | -1,007.18% | |
| -$1.26 | -$1.67 | -32.26% | |
| -$1.42 | N/A | +15.35% | |
| $5.15 | N/A | +407.88% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| $4.23M | N/A | - | |
| $300.28M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| +15.78% | ||
| -58.55% | ||
| +124.74% | ||
| -25.48% | ||
| 0.00% | ||
| -100.00% | ||
| +70.40% | ||
| -39.37% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $5.43 | ||
| $6.28 | ||
| $7.36 | ||
| $6.56 | ||
| $7.03 | ||
| -$0.50 | ||
| 1.02 | ||
| $0.85 | ||
| 39.16 | ||
| 236.91% | ||
| 78.67% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.67 | ||
| -$572.00K | ||
| - | ||
| -$29.52M | ||
| - | ||
| -$26.56M | ||
| - | ||
| -$28.95M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.01 | ||
| 2.59 | ||
| 2.59 | ||
| - | ||
| - | ||
| -0.18 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 3.95 | ||
| -3.24 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $30.20M | ||
| $41.27M | ||
| $49.14M | ||
| $48.96M | ||
| $18.94M | ||
| $18.94M | ||
| $199.00K | ||
| $199.00K | ||
| $301.00K |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.56M | ||
| $28.95M | ||
| $572.00K | ||
| $0.00 | ||
| $572.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$31.32M | ||
| -$12.10M | ||
| $46.47M | ||
| $24.00K | ||
| -$31.34M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Noble Capital Markets | → | |
| Benchmark | → | |
| HC Wainwright & Co. | → | |
| B. Riley Securities | → | |
| Benchmark | → | |
| Guggenheim | → | |
| Benchmark | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Benchmark | → |
Analyst sentiment
Institutional ownership
Screeners with UNCY
FAQ
What is the ticker symbol for Unicycive Therapeutics, Inc.?
The ticker symbol for Unicycive Therapeutics, Inc. is NASDAQ:UNCY
Does Unicycive Therapeutics, Inc. pay dividends?
No, Unicycive Therapeutics, Inc. does not pay dividends
What sector is Unicycive Therapeutics, Inc. in?
Unicycive Therapeutics, Inc. is in the Healthcare sector
What industry is Unicycive Therapeutics, Inc. in?
Unicycive Therapeutics, Inc. is in the Biotechnology industry
What country is Unicycive Therapeutics, Inc. based in?
Unicycive Therapeutics, Inc. is headquartered in United States
When did Unicycive Therapeutics, Inc. go public?
Unicycive Therapeutics, Inc. initial public offering (IPO) was on July 12, 2021
Is Unicycive Therapeutics, Inc. in the S&P 500?
No, Unicycive Therapeutics, Inc. is not included in the S&P 500 index
Is Unicycive Therapeutics, Inc. in the NASDAQ 100?
No, Unicycive Therapeutics, Inc. is not included in the NASDAQ 100 index
Is Unicycive Therapeutics, Inc. in the Dow Jones?
No, Unicycive Therapeutics, Inc. is not included in the Dow Jones index
When was Unicycive Therapeutics, Inc. last earnings report?
Unicycive Therapeutics, Inc.'s most recent earnings report was on August 14, 2025
When does Unicycive Therapeutics, Inc. report earnings?
The date for Unicycive Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- UNCY Official Website unicycive.com
- UNCY Profile on Yahoo Finance finance.yahoo.com/quote/UNCY
- UNCY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/uncy